Background Coronavirus-like particles (CoVLP) that are produced in plants and display the
prefusion spike glycoprotein of the original strain of severe acute respiratory syndrome …

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are being
deployed, but the global need greatly exceeds the supply, and different formulations might …

During the last decade, the spectre of an influenza pandemic of avian origin has led to a
revision of national and global pandemic preparedness plans and has stressed the need for …

A strain‐specific vaccine represents the best possible response to the threat of an influenza
pandemic. Rapid delivery of such a vaccine to the world's population before the peak of the …

The role of sucrose synthase (SuSy) in tomato fruit was studied in transgenic tomato (Lycopersicon
esculentum) plants expressing an antisense fragment of fruit-specific SuSy RNA (…

Plant‐based transient expression is potentially the most rapid and cost‐efficient system for
the production of recombinant pharmaceutical proteins, but safety concerns associated with …

The ability to express heterologous proteins in plants has led to the concept of using plants
as “bioreactors” or “biofactories” for the production of pharmaceutical proteins. Although …

Biopharmaceutical glycoproteins produced in plants carry N‐glycans with plant‐specific
residues core α(1,3)‐fucose and β(1,2)‐xylose, which can significantly impact the activity, …

Although antivirals are important tools to control severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, effective vaccines are essential to control the current …

The use of multiple copies of vectors based on either full‐length or deleted versions of cowpea
mosaic virus RNA‐2 for the production of heteromeric proteins in plants was investigated. …